Immunovia announces updated financial calendar
LUND (SWEDEN) – Immunovia (IMMNOV: Nasdaq Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024. Annual Report to be published April 29, 2024Q1 Report, 2024 April 29, 2024Annual General Meeting June 4, 2024Q2 Report, 2024 August 22, 2024Q3 Report, 2024 November 14, 2024 For more information, please contact: Karin Almqvist Liwendahl Chief Financial Officer karin.almqvist.liwendahl@